Creation of a successful multidisciplinary course in pediatric neuro‐oncology with a systematic approach to curriculum development

Abstract

Background The St Jude Global Academy Neuro‐Oncology Training Seminar (NOTS) is a hybrid course in pediatric neuro‐oncology specifically designed for physicians from low‐income and middle‐income countries. Methods The curriculum for the course was created by conducting a targeted needs assessment that evaluated 11 domains of care for children with central nervous system (CNS) tumors. The targeted needs assessment was completed by 24 institutions across the world, and the data were used to define 5 core elements included in the 2 components of the NOTS: a 9‐week online course and a 7‐day in‐person workshop. Participant acquisition of knowledge and changes in clinical behavior were evaluated as measures of success. Results Teams from 8 institutions located in 8 countries enrolled in the online course, and it was successfully completed by 36 participants representing 6 specialties. On the basis of their performance in the online course, 20 participants from 7 institutions took part in the on‐site workshop. The participants exhibited improved knowledge in core elements of treating children with CNS tumors, including barriers of care, possible solutions, and steps for project implementation (P < .0001). All participants expressed a belief that they acquired new concepts and knowledge, leading to changes in their clinical practice. Those present at the workshop created an international multidisciplinary group focused on treating CNS tumors in low‐income and middle‐income countries. Conclusions By using a hybrid online and in‐person approach, the authors successfully created a multidisciplinary course focused on pediatric CNS tumors for resource‐limited settings. Their experience supports this strategy as a feasible mechanism for driving further global collaborations.

Cure4Kids: Two decades of knowledge transfer

“…The data in this study concentrated on the volume of usage of the Cure4Kids content, which does not fully describe the value of the educational content and provide insight in the acquisition of knowledge and competencies. Courses deployed through Cure4Kids, with narrow learner pools and measured educational outcomes, have been previously described and shown increases in knowledge and obtainment of competencies 3,4 . Furthermore, future workstreams of Cure4Kids will focus on further investigating the outcomes and impact of the content distributed via the platform.…”

“…Courses deployed through Cure4Kids, with narrow learner pools and measured educational outcomes, have been previously described and shown increases in knowledge and obtainment of competencies. 3,4 Furthermore, future workstreams of Cure4Kids will focus on further investigating the outcomes and impact of the content distributed via the platform.…”

Development, Implementation, and Outcomes of a Global Infectious Disease Training Course

“…In the ensuing years, we conducted the program yearly using the 10-week blended learning design and expanded participation to all global regions. Also, our model guided the successful design and implementation of other thematic global training courses, including a neuro-oncology training 9 and a critical care course.…”

“…Two thematic courses, critical care and neuro-oncology, were built and implemented following our methodology. 9 Globalization and dynamic exchange of disease-related data, as well as expertise and knowledge, are teaching us that maximizing the use of virtual education and training platforms by using modern training delivery methodology and collaboration, as we have successfully done, is becoming the norm in education.…”

Treatment barriers and clinical outcome of children with medulloblastoma in China: a report from the Chinese Children’s Cancer Group (CCCG)

“…This highlights the need for further reinforcement of the current evidence through structured cross-disciplinary training. 31 Moreover, the variation in practice among centers reflects practical restrictions on service delivery. For the choice of chemotherapeutic agents, lomustine is often unavailable in mainland China and when available, increasingly costly; cyclophosphamide, while proven to be equally effective and widely being adopted in MB protocols, requires additional in-patient days when compared with oral alkylating agents.…”